More articles from Editorial

  • The HPV vaccine: Understanding and addressing barriers to vaccination
    Pelin Batur, MD
    Cleveland Clinic Journal of Medicine September 2020, 87 (9) 545-548; DOI: https://doi.org/10.3949/ccjm.87a.20082

    Key steps include optimizing clinician-patient communication.

  • Cardiac troponin testing: Goodbye, ‘troponinemia’
    Anirudh Kumar, MD, Divyang R. Patel, MD and Venugopal Menon, MD
    Cleveland Clinic Journal of Medicine August 2020, 87 (8) 483-484; DOI: https://doi.org/10.3949/ccjm.87a.20013

    Any troponin elevation is prognostically important; dismissing it as “troponinemia” is no longer a viable strategy.

  • Device-based therapies for resistant hypertension in chronic kidney disease: The continuing quest for a cure
    George Thomas, MD
    Cleveland Clinic Journal of Medicine July 2020, 87 (7) 444-447; DOI: https://doi.org/10.3949/ccjm.87a.20092

    Device-based therapies have shown promise, but many points still need clarification.

  • Denosumab cessation
    Chad L. Deal, MD
    Cleveland Clinic Journal of Medicine June 2020, 87 (6) 339-341; DOI: https://doi.org/10.3949/ccjm.87a.20040

    Bone loss is rapid if patients miss injections. Clinicians can take extra measures to ensure patients get appropriate treatment.

  • Preventing migraine: The old and the new
    Glen D. Solomon, MD
    Cleveland Clinic Journal of Medicine April 2020, 87 (4) 219-221; DOI: https://doi.org/10.3949/ccjm.87a.19147

    Roughly half of patients taking any preventive medication have a 50% reduction in migraine frequency.

  • Atypical anorexia nervosa can be just as bad
    Neville H. Golden, MD and Philip S. Mehler, MD
    Cleveland Clinic Journal of Medicine March 2020, 87 (3) 172-174; DOI: https://doi.org/10.3949/ccjm.87a.19146

    Eating disorders can occur in patients with a wide variety of weights.

  • Gene therapy in sickle cell disease: Possible utility and impact
    Susanna A. Curtis, MD, MS and Niketa C. Shah, MD
    Cleveland Clinic Journal of Medicine January 2020, 87 (1) 28-29; DOI: https://doi.org/10.3949/ccjm.87a.19124

    CRISPR-Cas9 makes it possible to edit the patient’s own genes, but questions remain.

  • ACE inhibitor and ARB therapy: Practical recommendations
    Hernan Rincon-Choles, MD, MS
    Cleveland Clinic Journal of Medicine September 2019, 86 (9) 608-611; DOI: https://doi.org/10.3949/ccjm.86a.19016

    Inhibitors of the renin-angiotensin-aldosterone system are cornerstones of therapy of cardiovascular disease.

  • Aspirin: 4,000 years and still learning
    Kenneth C. Cummings, MD, MS, FASA
    Cleveland Clinic Journal of Medicine August 2019, 86 (8) 522-524; DOI: https://doi.org/10.3949/ccjm.86a.19041

    What we know about aspirin—and what we still need to learn.

  • Where have all the children gone? Intentional communities for adults with autism
    Carl R. Brass, LPCC-S, MA and Debra J. Mandell, OTR/L, MA
    Cleveland Clinic Journal of Medicine August 2019, 86 (8) 554-558; DOI: https://doi.org/10.3949/ccjm.86a.19080

    Children with ASD grow to be adults with ASD, with complex healthcare needs.

Pages